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Abstract  Maternal  hypotension  is  a  common  complication  after  spinal  anesthesia  for  cesarean
section,  with  deleterious  effects  on  the  fetus  and  mother.  Among  the  strategies  aimed  at  min-
imizing  the  effects  of  hypotension,  vasopressor  administration  is  the  most  efﬁcient.  The  aim
of  this  study  was  to  compare  the  efﬁcacy  of  phenylephrine,  metaraminol,  and  ephedrine  in
the  prevention  and  treatment  of  hypotension  after  spinal  anesthesia  for  cesarean  section.
Ninety  pregnant  women,  not  in  labor,  undergoing  cesarean  section  were  randomized  into  three
groups  to  receive  a  bolus  followed  by  continuous  infusion  of  vasopressor  as  follows:  phenyle-
phrine  group  (50  g  +  50  g/min);  metaraminol  group  (0.25  mg  +  0.25  mg/min);  ephedrine  group
(4  mg  +  4  mg/min).  Infusion  dose  was  doubled  when  systolic  blood  pressure  decreased  to  80%  of
baseline  and  a  bolus  was  given  when  systolic  blood  pressure  decreased  below  80%.  The  infusion
dose  was  divided  in  half  when  systolic  blood  pressure  increased  to  120%  and  was  stopped  when
it  became  higher.  The  incidence  of  hypotension,  nausea  and  vomiting,  reactive  hypertension,
bradycardia,  tachycardia,  Apgar  scores,  and  arterial  cord  blood  gases  were  assessed  at  the  1st
and  5th  minutes.
There was  no  difference  in  the  incidence  of  hypotension,  bradycardia,  reactive  hypertension,
infusion  discontinuation,  atropine  administration  or  Apgar  scores.  Rescue  boluses  were  higher
only  in  the  ephedrine  group  compared  to  metaraminol  group.  The  incidence  of  nausea  and
vomiting  and  fetal  acidosis  were  greater  in  the  ephedrine  group.  The  three  drugs  were  effective
in  preventing  hypotension;  however,  fetal  effects  were  more  frequent  in  the  ephedrine  group,
although  transient.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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Avaliac¸ão  comparativa  entre  metaraminol,  fenilefrina  e  efedrina  na  proﬁlaxia  e  no
tratamento  da  hipotensão  em  cesarianas  sob  raquianestesia
Resumo  Hipotensão  materna  é  uma  complicac¸ão  comum  após  raquianestesia  em  cirurgia
cesariana,  trazendo  efeitos  deletérios  para  o  feto  e  a  mãe.  Entre  as  estratégias  com  o  objetivo
de  minimizar  os  efeitos  da  hipotensão,  a  administrac¸ão  de  vasopressores  é  a  mais  eﬁciente.
O  objetivo  deste  estudo  foi  comparar  a  eﬁcácia  da  fenilefrina,  metaraminol  e  efedrina  na
prevenc¸ão  e  tratamento  de  hipotensão  após  raquianestesia  em  cirurgia  cesariana.  Noventa
gestantes  que  não  estavam  em  trabalho  de  parto  submetidas  à  cesariana  eletiva  foram  ran-
domizadas  em  três  grupos  para  receber  um  bolus,  seguido  de  infusão  contínua  de  vasopressor
da seguinte  forma:  Grupo  Fenilefrina  (50  g  +  50  g/min);  Grupo  Metaraminol  (0,25  mg  +  0,25
mg/min);  Grupo  Efedrina  (4  mg  +  4  mg/min).  A  dose  da  infusão  foi  dobrada  quando  a  pressão
arterial  sistólica  (PAS)  decresceu  até  80%  dos  valores  basais  e  um  bolus  foi  dado  quando  a  PAS
decresceu  para  valores  abaixo  de  80%.  A  dose  da  infusão  foi  dividida  ao  meio  quando  a  PAS
aumentou  até  120%  e  foi  interrompida  quando  mais  elevada.  Foram  analisadas  as  incidências
de  hipotensão,  náuseas  e  vômitos,  hipertensão  reativa,  bradicardia,  taquicardia  e  escores  de
Apgar  no  primeiro  e  quinto  minutos  e  gases  de  sangue  arterial  do  cordão  umbilical.
Não houve  diferenc¸as  nas  incidências  de  hipotensão,  bradicardia,  hipertensão  reativa,
interrupc¸ão  da  infusão,  administrac¸ão  de  atropina  ou  escores  de  Apgar.  A  administrac¸ão  de
bolus  de  resgate  foram  superiores  apenas  no  Grupo  Efedrina  em  comparac¸ão  com  Metaraminol.
A  incidência  de  náuseas  e  vômitos  e  acidose  fetal  foram  superiores  no  Grupo  Efedrina.  Os
três  fármacos  foram  eﬁcazes  na  prevenc¸ão  de  hipotensão,  mas  repercussões  fetais  foram  mais
frequentes  no  Grupo  Efedrina,  embora  transitórias.
©  2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  
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ion No  174/11.  Pregnant  women  were  included  in  the  study
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aternal  hypotension  after  spinal  anesthesia  for  cesarean
ections is  a  common  complication  and  may  occur  in  up  to
0% of  cases.1 If  not  treated  promptly,  it  can  cause  unde-
ired effects  on  the  mother  and  fetus.2 The  effects  that  most
ommonly affect  mothers  are  nausea  and  vomiting,  although
ore serious  complications  such  as  circulatory  collapse  and
ardiac arrest  may  occur  if  treatment  is  not  prompt  and  efﬁ-
ient. In  the  fetus,  placental  hypoperfusion  may  cause  fetal
istress, resulting  in  fetal  acidosis,  increased  base  excess
nd low  Apgar  values.3
Several  strategies  have  been  used  to  prevent  or  minimize
ypotension, such  as  infusion  of  intravenous  ﬂuids,  uter-
ne displacement  to  the  left  and  elastic  compression  of  the
ower limbs.  However,  these  measures  alone  are  generally
ot effective.  The  use  of  vasopressors  is  required.4
The  optimal  vasopressor  should  offset  the  progressive
ffects of  ascending  sympathetic  blockade,  which  is  difﬁ-
ult to  achieve  because  the  -  and  -adrenergic  activities
an vary  independently  during  blockade  installation.  Still,
hanges in  sympathetic  activity  may  be  organ-speciﬁc  (inhi-
ition of  cardiac  ﬁbers),  region-speciﬁc  (inhibition  in  the
ower body  and  increased  activity  in  the  upper  body)  or
ystemic (inhibition  of  catecholamine  release  from  the
drenal medulla).  The  most  commonly  used  vasopressors
phenylephrine, metaraminol,  and  ephedrine)  have  primar-
ly systemic  effects  and  may  have  undesirable  effects  on
rgans, vascular  beds  or  fetus.5Ephedrine  is  a  non-catecholamine  sympathomimetic
gent that  stimulates  the  -  and  -adrenergic  receptors
y direct  and  indirect  action.  It  became  the  vasopressor  of
o
c
ihoice  for  treatment  and  prophylaxis  of  hypotension  after  a
tudy with  sheep  in  the  70Ys,  which  showed  minimal  changes
n uterine  blood  ﬂow  after  administration,  while  drugs  with
redominant -agonist  effect  caused  a  signiﬁcant  reduction
n the  ﬂow.6
However,  the  supremacy  of  ephedrine  as  a vasopres-
or of  choice  in  cesarean  sections  began  to  be  questioned
fter its  association  with  fetal  acidosis  and  lower  values  of
ase excess  compared  to  vasopressors  with  predominant  -
gonist effect.  This  fact  is  explicable  because  ephedrine
rosses the  uteroplacental  barrier,  acts  directly  on  the
etus, and  increases  its  metabolism  through  2-adrenergic
eceptors.7 The  administration  of  ephedrine  for  cesarean
ections, besides  causing  fetal  acidosis,  also  became  asso-
iated with  the  highest  incidence  of  maternal  nausea  and
omiting.8
The  aim  of  this  study  was  to  compare  the  efﬁcacy
f phenylephrine,  metaraminol  and  ephedrine  for  the
revention and  treatment  of  maternal  hypotension  dur-
ng cesarean  section,  evaluate  vasopressor  therapy-related
dverse effects,  and  study  fetal  changes  through  Apgar  score
nd  umbilical  cord  arterial  and  venous  blood  gases.
ethodology
his  study  was  approved  by  the  Research  Ethics  Committee
f the  Hospital  Universitário  Presidente  Dutra,  under  Opin-nly after  signing  the  informed  consent  form.  A  randomized,
ontrolled, double-blind  clinical  trial  was  performed  involv-
ng pregnant  women  with  gestational  age  between  39  weeks
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in order  to  enable  greater  effectiveness  in  controlling  blood
pressure.17 Thus,  the  rate  of  infusion  of  vasopressors  was
adjusted according  to  the  protocol  as  shown  in  Table  1.
Table  1  Vasopressor  infusion  rates.
SBP  values  (%)  Approach
Above  120%  Infusion  discontinuation  until  SBP  return
to  <120%
100  and  120%  Reduction  of  infusion  rate  to  15  mL/h
Around  100%  Maintenance  of  infusion  rate  at  30  mL/hComparison  of  metaraminol,  phenylephrine  and  ephedrine  
and  one  day  and  40  weeks  and  six  days,  undergoing  elective
cesarean delivery  in  a  private  maternity  hospital  of  São  Luís
(MA).
Sample
The  primary  outcome  was  the  umbilical  artery  pH,  which
served as  the  basis  for  sample  calculation.  With  data  from
previous studies,  it  was  calculated  that  a  sample  of  26
pregnant women  per  group  would  have  90%  power  with  a
signiﬁcance level  of  5%  to  detect  a  difference  of  0.05  units
in the  umbilical  artery  pH  between  groups.  However,  in  order
to minimize  possible  losses,  the  inclusion  was  scheduled  for
30 pregnant  women  in  each  group.
Inclusion,  non-inclusion  and  exclusion  criteria
Pregnant  women  between  39  weeks  and  one  day  and  40
weeks and  six  days  of  gestational  age,  undergoing  elective
cesarean delivery,  physical  status  ASA  I  (American  Society
of Anesthesiologists’  classiﬁcation),  with  a  single  gestation
and between  20  and  34  years  old  were  included  in  the
study, as  this  age  group  is  indifferent  to  maternal  and  fetal
complications.9
It  is  well  documented  that  pregnant  women  over  35
years of  age  are  more  likely  to  have  premature  rup-
ture of  membranes,  placenta  praevia,  gestational  diabetes
and preeclampsia,  in  addition  to  a  higher  chance  of  hav-
ing chronic  diseases,  such  as  systemic  hypertension10;  and
pregnant women  under  20  years  of  age  have  a  higher  risk  of
fetal death.11
Non-inclusion  criteria  were  pregnant  women  refusal,
comorbidities, fetal  abnormalities,  contraindication  for
spinal anesthesia  and  a  history  of  hypersensitivity  to  drugs
used in  the  study.
Exclusion  criteria  were  volume  of  collected  umbilical
cord blood  insufﬁcient  to  determine  blood  gases  and  anes-
thetic block  failure.
Treatment  groups
Pregnant  women  were  randomly  divided  into  three  groups:
metaraminol (Group  M);  phenylephrine  (Group  P);  ephedrine
(Group E).  The  method  used  was  the  drawing  of  sequential
sealed envelopes  containing  numbers  previously  generated
by computer.  Both  pregnant  women  and  anesthesiologists
who participated  in  the  surgeries  were  blinded  to  group
allocation.
Preparation  of  vasopressors
A  second  anesthetist,  who  did  not  attend  the  surgery,  pre-
pared the  vasopressor  agents.  The  solutions  were  prepared
in a  syringe  of  20  mL  as  follows:•  Group  P:  phenylephrine  100  g/mL;
•  Group  M:  metaraminol  0.5  mg/mL;
•  Group  E:  ephedrine  8  mg/mL.301
nesthetic  technique
atients  were  monitored  with  continuous  electrocardiogra-
hy, noninvasive  blood  pressure  and  pulse  oximetry,  with
nﬁnity Delta  monitor  (Drägerwerk  AG  &  Co.  KGaA,  2009).
Venipuncture  with  an  18G  Jelco  was  performed  and  then
atients were  placed  supine,  with  uterine  displacement  to
he left  for  a  few  minutes.  Then,  blood  pressure  was  mea-
ured three  times  at  3-min  intervals  and  the  arithmetic
verage of  the  values  was  calculated,  which  was  consid-
red the  basal  pressure  of  pregnant  women  and  recorded  on
he data  collection  form.  Then,  with  the  patient  in  sitting
osition, spinal  anesthesia  was  performed  with  27G  needle
Whitacre) between  the  third  and  fourth  lumbar  vertebrae.
atients received  10  mg  of  0.5%  hyperbaric  bupivacaine  com-
ined  with  100  g  of  morphine,  at  a  rate  of  1  mL  every  15  s.12
mmediately  after  the  blockade,  concomitant  hydration  of
inger’s lactate  (10  mL  kg--1) was  started.13
After  blockade,  the  measurement  of  pregnant  women
ystolic blood  pressure  (SBP)  was  recorded  every  minute
n data  collection  form  up  to  fetus  extraction.  The  level
f sensory  block  was  assessed  with  the  pinprick  test  every
inute after  the  puncture,  until  it  reached  the  dermatome
evel of  the  ﬁfth  thoracic  nerve  root  (T5).  The  beginning
f surgery  was  then  authorized.  The  time  from  blockade  to
kin incision,  uterine  incision,  and  extraction  of  fetus  were
ecorded.12
rotocol  for  administration  of  vasopressors
mmediately  after  blockade,  the  patients  received  a  bolus
f 0.5  mL  of  the  solution,  which  corresponded  to  50  g
f phenylephrine,  250  g  of  metaraminol,  and  4  mg  of
phedrine, followed  by  subsequent  doses  of  continuous
ntravenous infusion  with  a  syringe  pump  (Samtronic  Saúde
echnologia, model  670),  programmed  for  an  infusion  rate
f 30  mL/h,  so  that  all  patients  received  the  doses  previously
stablished:
 Group  P:  phenylephrine  50  g/min--1;14
 Group  M:  Metaraminol  250  g/min--1;15
 Group  E:  ephedrine  4 mg  g/min--1.16
Although  infusion  with  ﬁxed  rates  is  easier  to  perform,
arying infusion  rates  were  used  according  to  the  SBP  values,80  and  100%  Increase  of  infusion  rate  to  60  mL/h
Below  80%  Solution  bolus  of  1  mL  (rescue  dose)  and
increased infusion  to  60  mL/h
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Reactive  hypertension  after  the  use  of  vasopressor  was
eﬁned as  SBP  20%  greater  than  the  baseline  value  and,  if  it
ccurred, it  was  treated  with  infusion  discontinuation  until
lood pressure  reached  values  lower  than  120%  of  baseline,
nd the  infusion  was  restarted.  When  patient  had  more  than
wo episodes  of  reactive  hypertension,  infusion  was  perma-
ently discontinued  (which  was  recorded),  and  subsequent
pisodes of  hypotension  were  treated  with  bolus  infusion  of
he solution  (1  mL).  Bradycardia  was  considered  when  heart
ate values  were  lower  than  50  beats  per  minute  and,  when
ccompanied by  hypotension,  it  was  treated  with  atropine
0.5 mg).  Tachycardia  was  considered  at  a  heart  rate  greater
han 100  beats  per  minute.12 Values  less  than  100%  of  base-
ine SBP  were  considered  hypotension.
valuation  of  pregnant  woman
aternal  SBP  were  recorded  every  minute  on  data  collection
orm. Episodes  of  hypotension,  hypertension,  tachycardia
nd bradycardia,  need  for  rescue  doses  of  vasopressor,
nfusion discontinuation,  and  atropine  administration  until
irth were  recorded.  Episodes  of  nausea  and  vomiting  were
lso recorded  until  the  end  of  cesarean  section  and,  if  it
ccurred, it  was  treated  with  4  mg  intravenous  ondansetron.
ewborn  evaluation
rterial  blood  samples  were  collected  from  the  fetal  umbil-
cal cord  immediately  after  birth,  and  during  the  clamp,  the
urgeon was  requested  to  withdraw  a  fragment  of  about
0 cm  long  for  arterial  puncture.  At  the  operating  room,
nalysis of  blood  gas,  lactate,  and  glucose  was  performed
sing a  portable  gas  analysis  device  (Epoc,  Epocal  Inc.,
ttawa, Canada).  An  umbilical  pH  less  than  7.2  was  con-
idered fetal  acidosis.18Newborns  were  evaluated  by  an  assistant  pediatrician
ho assessed  the  Apgar  score  at  the  1st  and  5th  minutes
f birth,  and  a  low  Apgar  was  considered  when  the  values
ssigned were  less  than  7.
t
o
s
m
Table  2  Hemodynamic  changes  related  to  maternal  sympathetic
pregnant  women  undergoing  elective  cesarean  section  under  spina
Metaraminol
n  =  30
Phe
n  =
Hypotension  5  (16.7%)  6  (2
Hypertension  11  (36.7%)  7  (2
Bradycardia  3  (10%)  3  (1
Tachycardia  1  (3.3%)  0  (0
Rescue  dose  2  (6.7%)  5  (1
Nausea  1  (3.3%)  1  (3
Vomiting  1  (3.3%)  1  (3
Discontinuation  3  (10%)  3  (1
Atropine  2  (6.7%)  2  (6
Results are expressed as frequency (percentage) (chi-square, Fisher).
a p = 0.0004 versus metaraminol; p = 0.0 versus phenylephrine.
b p = 0.0102 versus metaraminol; p = 0.1432 versus phenylephrine.
c p = 0.0056 versus metaraminol; p = 0.0056 versus phenylephrine.
d p = 0.0056 versus metaraminol; p = 0.0056 versus phenylephrine.F.F.  de  Aragão  et  al.
The  newborn  destination  was  also  evaluated,  if  he  was
aken to  the  neonatal  intensive  care  unit,  if  he  was  under
bservation in  the  neonatal  resuscitation  room  or  taken  to
he apartment.
tatistical  analysis
he  results  were  statistically  analyzed  with  the  software
ioEstat 5.3.  Numerical  variables  were  compared  among  the
hree groups  using  the  Kruskal--Wallis  test  followed  by  the
ann--Whitney test.  Categorical  variables  were  compared
mong the  three  groups  using  the  chi-square  test  followed
y Fisher’s  exact  test.  Results  were  considered  statistically
igniﬁcant when  p  <  0.05.
esults
mong  the  three  groups,  all  pregnant  women  were  over  20
nd under  35  years  of  age,  gestational  age  between  39  weeks
nd one  day  and  40  weeks  and  six  days  and,  until  birth,  they
eceived the  same  amount  of  ﬂuids.
One  of  the  pregnant  women  who  received  ephedrine  was
xcluded due  to  insufﬁcient  volume  of  blood  collected  from
he umbilical  cord.
Pregnant women  evaluation  showed  no  signiﬁcant  differ-
nce regarding  the  incidence  of  hypotension  in  the  three
roups, as  well  as  incidence  of  reactive  hypertension,  need
or infusion  discontinuation,  and  bradycardia.  Regarding  res-
ue dose  administration,  there  was  no  statistical  difference
etween groups  M  and  E,  although  higher  in  Group  E,  which
as not  observed  in  Group  P.  The  incidence  of  tachycardia,
ausea and  vomiting  was  higher  in  Group  E  (Table  2).
Clinical  evaluation  of  newborns  showed  no  difference
n Apgar  scores  at  the  1st  or  5th  minute  between  groups
Table 3).  Only  one  newborn  in  Group  E  had  Apgar  score  less
han seven  at  the  1st  minute,  associated  with  fetal  acid-
sis. However,  he  showed  clinical  improvement  and  Apgar
core =  9  at  the  5th  minute.  No  infant  received  resuscitation
aneuvers or  required  care  in  the  intensive  care  unit.
 block  and  side  effects  secondary  to  vasopressor  therapy  in
l  anesthesia.
nylephrine
 30
Ephedrine
n  =  29
p
0%)  10  (34.5%)  0.23
3.3%)  8  (27.6%)  0.51
0%)  0  (0%)  0.24
%)  12  (41.4%)a <0.0001
6.7%)  10  (33.3%)b 0.02
.3%)  9  (31.0%)c 0.001
.3%)  9  (31.0%)d 0.001
0%)  5  (17.2%)  0.62
.7%)  0  (0%)  0.36
Comparison  of  metaraminol,  phenylephrine  and  ephedrine  303
Table  3  Clinical  evaluation  of  the  newborn  through  the  Apgar  test  at  the  1st  and  5th  minutes  after  birth  in  elective  cesarean
sections  under  spinal  anesthesia.
Apgar  Metaraminol  Phenylephrine  Ephedrine  p
1st  minute  9  (7--9)  9  (8--9)  9  (6--9)  0.7413
 (9--1
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i5th  minute  10  (9--10)  10
Values are expressed as median and interquartile range (Kruskal--
Regarding  laboratory  evaluation  of  newborns,  the  aver-
age pH  was  7.31  ±  0.03  in  Group  M,  7.30  ±  0.03  in  Group
P and  7.26  ±  0.07  in  Group  E.  In  group  E,  three  newborns
(10.3%) had  pH  less  than  7.20.  However,  the  p-value  was
signiﬁcant (p  =  0.0035).
Considering  the  mean  value  of  excess  base,  there  was
a signiﬁcant  difference  between  groups  M  and  P  in  rela-
tion to  E,  but  not  between  groups  M  and  P.  Lactate  values
also showed  signiﬁcant  difference  between  groups  and  were
higher  in  Group  E  compared  to  groups  M  and  P.  Parameters
such as  pO2,  pCO2,  HCO3,  and  glucose  showed  no  statistical
differences (Table  4).
There  was  no  statistical  difference  between  groups
regarding the  time  elapsed  between  blockade  and  skin  inci-
sion, blockade  and  uterine  incision,  and  blockade  and  birth
(Table 5).
Discussion
The  vasopressor  doses  administered  in  this  study  were
appropriate for  the  prevention  and  treatment  of  maternal
hypotension. Currently,  it  is  known  that  the  three  vaso-
pressors are  considered  equally  effective  for  preventing
hypotension during  elective  cesarean  sections.3,15,19
When  phenylephrine  is  administered  by  continuous  infu-
sion, the  incidence  of  hypotension  varies  between  13%  and
23%.17 Allen  et  al.14 compared  ﬁxed  infusions  of  25,  50,  75
and 100  g/min  of  phenylephrine  and  reported  better  hemo-
dynamic stability  when  doses  of  25  and  50  g/min  were
used. The  incidence  of  hypotension  in  this  study  was  20%
and satisfactory  hemodynamic  control  was  obtained  with  the
variable infusion  started  with  50  g/min.
In a  study  by  Ngan  Kee  et  al.,15 in  which  metaraminol
was administered  as  a  bolus  of  0.5  mg  followed  by  contin-
uous infusion  of  0.25  mg/min,  the  incidence  of  hypotension
g
w
t
b
Table  4  Laboratory  evaluation  of  the  newborn  performed  with  sa
ment  of  glucose,  lactate,  and  blood  gases  during  elective  cesarean
Metaraminol  Ph
Ph  7.31  ±  0.03  7
pO2 (mm  Hg)  17.32  ±  11.67  12
pCO2 (mm  Hg)  49.25  ±  7.97  53
HCO3 (mm  Hg)  24.77  ±  2.99  25
Base  excess  (mEq  L--1) −1.71  ±  2.63  −1
Glicemia  51.53  ±  9.72  50
Lactate  1.46  ±  0.31  1
Values are expressed as mean and standard deviation (Kruskal--Wallis, 
a p = 0.0024 versus metaraminol; p = 0.0177 versus phenylephrine.
b p = 0.0018 versus metaraminol; p = 0.0003 versus phenylephrine.
c p = 0.0002 versus metaraminol; p = 0.0017 versus phenylephrine.0)  10  (9--10)  0.7542
s).
as  35%,  which  is  higher  than  that  obtained  in  this  study
16.7%). Although  the  initial  infusion  doses  in  both  stud-
es were  similar,  the  difference  observed  probably  occurred
ecause the  doses  administered  in  this  study  varied  accord-
ng to  blood  pressure  measurements,  which  promotes  better
emodynamic control.17
Regarding  ephedrine,  this  study  observed  hypotension  in
4.5% of  cases,  whereas  in  the  study  by  Carvalho  et  al.,20
he  incidence  was  45%.  Note  that  both  the  work  by  Ngan
ee et  al.15 and  Carvalho  et  al.  used  prior  administration
f crystalloid,  an  approach  proven  ineffective.  Because  in
his study  ﬂuids  were  concomitantly  administered  with  the
lockade, this  may  explain  the  difference  in  results.
On  the  other  hand,  Bhardwaj  et  al.21 in  a  study  comparing
he three  vasopressors  used  in  the  present  study,  adminis-
ered bolus  followed  by  continuous  infusion  and  reported
ncidence of  hypotension  in  Group  M  (14.8%)  and  Group
 (12.5%),  results  closest  to  this  study.  As  for  ephedrine,
ypotension occurred  in  23%  of  the  cases.
To  avoid  distortions  in  the  results,  all  patients  received  a
olume of  10  mL/kg  of  Ringer’s  solution  until  child  delivery,
s concomitant  hydration  (cohydration).  Banerjee  et  al.22
onsidered  rational  to  start  the  rapid  infusion  of  crystalloid,
uch as  Ringer’s  solution,  concurrently  with  the  anesthetic
lock, as  crystalloids  improve  systolic  volume  and  cardiac
utput only  transiently,  and  it  is  considered  a  cheaper  option
han colloids,  with  less  risk  of  complications  (anaphylaxis,
oagulation disorders).23
In  cases  of  reactive  hypertension  and  vasopressor  infusion
iscontinuation, the  results  match  those  of  the  literature,19
.e.,  there  were  no  signiﬁcant  differences  among  the  three
roups. Regarding  the  incidence  of  bradycardia,  although  it
as similar  in  the  three  groups,  the  results  are  opposite  to
he studies  by  Veeser  et  al.,  which  reported  lower  risk  of
radycardia in  pregnant  women  receiving  ephedrine.
mple  collection  of  umbilical  cord  arterial  blood  for  measure-
 section  under  spinal  anesthesia.
enylephrine  Ephedrine  p
.30  ±  0.03  7.26  ±  0.07a 0.0035
.82  ±  3.76  14.21  ±  6.18  0.1139
.09  ±  7.19  53.98  ±  11.96  0.1681
.78  ±  2.37  23.80  ±  3.46  0.0745
.22  ±  1.98  −3.44  ±  2.39b 0.0005
.60  ±  9.84  49.76  ±  11.32  0.6545
.58  ±  0.53  2.11  ±  0.69c 0.0004
Mann--Whitney).
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Table  5  Intraoperative  variables.
Metaraminol  (min)  Phenylephrine  (min)  Ephedrine  (min)  p
Blockade-skin  incision  7.53  ±  2.10  6.67  ±  2.55  6.97  ±  1.97  0.37
Blockade-uterine  incision  13.03  ±  3.90  11.17  ±  3.79  12.52  ±  3.52  0.27
Blockade-birth  14.17  ±  3.96  12.47  ±  3.81  13.69  ±  3.53  0.34
Skin  incision-birth  6.73  ±  2.49  5.73  ±  2.39  6.62  ±  2.32  0.21
Uterine  incision-birth  1.17  ±  0.46  1.30  ±  0.53  1.17  ±  0.38  0.41
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oValues are expressed as mean and standard deviation (Kruskal--Wa
An  interesting  observation  was  that  pregnant  women
reated with  metaraminol  had  less  need  for  rescue  doses
han those  who  received  ephedrine.  The  same  was  not
bserved with  phenylephrine.  This  probably  occurred
ecause metaraminol  increases  the  systemic  vascular  resis-
ance (afterload),  recruits  splanchnic  blood,  and  increases
he venous  return  (preload),  besides  presenting  positive
notropic activity,  unlike  phenylephrine,  which  acts  basically
nly in  the  afterload.24
The  incidence  of  tachycardia  was  higher  in  Group  E
han in  other  groups,  which  was  expected  because  when
phedrine is  used  to  prevent  hypotension  during  surgery
nder spinal  anesthesia,  it  causes  an  increase  of  cardiac  out-
ut at  the  expense  of  increased  heart  rate.  On  the  other
and, it  is  known  that  -agonist  drugs,  such  as  phenyle-
hrine and  metaraminol,  may  cause  reﬂex  bradycardia  to
he increased  peripheral  vascular  resistance.25 However,
here were  no  differences  between  groups  in  the  incidence
f bradycardia,  which  may  be  due  to  the  administration  of
dequate doses  of  metaraminol  and  phenylephrine.
In  this  study,  despite  effective  blood  pressure  control,
here was  a  relationship  between  the  use  of  ephedrine  and
he incidence  of  nausea  and  vomiting.  Lee  et  al.,2 in  a  sys-
ematic review  on  the  use  of  ephedrine,  found  that  even
nder blood  pressure  control  in  cesarean  sections  there  were
ifferences  between  the  ephedrine  group  and  the  control
roup (without  vasopressor)  regarding  the  occurrence  of
ausea and  vomiting.
Ngan Kee  et  al.,26 in  a  study  comparing  infusions  with
arying combinations  of  ephedrine  and  phenylephrine  for
aintenance of  blood  pressure  during  elective  cesarean  sec-
ion, found  that  the  higher  the  proportion  of  ephedrine  and
he lower  the  proportion  of  phenylephrine,  the  hemody-
amic control  was  more  difﬁcult,  fetal  acid-base  proﬁle  less
avorable, and  incidence  of  nausea  and  vomiting  higher.
It  is  known  that  intraoperative  nausea  and  vomiting  in
esarean sections  may  be  prevented  through  hypotension
ontrol and  improving  the  use  of  neuraxial  and  intravenous
pioids, which  improves  the  anesthetic  block  quality,  mini-
izes surgical  stimulation,  and  reduces  the  use  of  uterotonic
rugs. Whereas  all  pregnant  women  in  this  study  received
he same  dose  of  opioids  and  uterotonic  drugs,  as  well
s adequate  levels  of  anesthetic  blockade,  the  increased
ncidence of  nausea  and  vomiting  caused  by  ephedrine
s probably  due  to  an  effect  of  the  drug  itself,  besides
ndicating that  the  etiology  of  nausea  and  vomiting  is
ultifactorial.27
Some  studies  have  reported  a  lower  incidence  of  nau-
ea, vomiting,  and  maternal  hypotension  when  vasopressors
re administered  by  continuous  infusion.  Therefore,  in  this
t
n
c
dtudy,  the  administration  of  bolus  followed  by  continuous
nfusion was  chosen.6,17,28 However,  it  is  known  that  continu-
us infusion  of  vasopressors  is  associated  with  higher  doses  in
rder to  maintain  blood  pressure  close  to  baseline  values.29
The  vasopressor  of  choice  with  better  proﬁle  for  hemo-
ynamic control  of  pregnant  women  in  cesarean  sections
s still  largely  debatable,  by  the  observation  that  during
he anesthetic  block  installation  there  is  a reduction  in  sys-
emic vascular  resistance,  associated  with  increased  cardiac
utput, which  is  mediated  by  increased  heart  rate.  Thus,
radycardia caused  by  the  administration  of  -agonists
esults in  decreased  maternal  cardiac  output,  leading  some
nesthesiologists to  base  their  choice  on  the  mother’s  heart
ate.30
Dyer  et  al.,  in  a  study  evaluating  pregnant  women  under-
oing cesarean  section  under  spinal  anesthesia  through
inimally invasive  cardiac  output  monitors  (LiDDCO  and
ioZ) who  received  ephedrine  or  phenylephrine,  showed
hat, after  spinal  anesthesia,  the  pregnant  women  had  a
arked decrease  in  systemic  vascular  resistance,  with  a
ompensatory increase  in  cardiac  output,  and  concluded
hat low  doses  of  phenylephrine  are  able  to  restore  the
ystemic vascular  resistance  and  cardiac  output  to  baseline
alues.31
Auler  et  al.32 who  also  assessed  maternal  hemodynamic
hanges through  minimally  invasive  monitoring  of  pregnant
omen undergoing  cesarean  section  under  spinal  anesthe-
ia and  who  received  metaraminol  to  control  blood  pressure,
eported a  decrease  in  systolic  volume,  offset  by  increased
eart rate,  but  did  not  observe  signiﬁcant  changes  in  mean
rterial pressure  and  systemic  vascular  resistance,  and  spec-
lated that  these  results  occurred  because  of  more  rapid
nd effective  correction  of  mean  arterial  pressure  by  the
dministration of  metaraminol.
Although  the  hemodynamic  control  was  satisfactory  with
he three  vasopressors,  a  limitation  of  the  study  was  that
he doses  administered  were  extracted  from  other  stud-
es without  equipotent  ratio,  as  there  are  no  studies  in
iterature comparing  equipotent  doses  of  vasopressors  stud-
ed. Still,  measurement  of  maternal  pressure  was  used  at
ntervals of  one  minute,  which  besides  being  uncomfortable
or the  mother  may  hinder  blood  pressure  measurement,
s sometimes  it  takes  more  than  a  minute  to  measure
lood pressure.  Cooper  et  al.33 in  a  study  evaluating  the
ontrol of  systolic  blood  pressure  with  continuous  infusion
f phenylephrine  for  elective  cesarean  sections,  showed
hat infusion  rate  adjustments  with  measurement  of  mater-
al blood  pressure  at  2-min  intervals  are  effective  for
ontrolling hypotension  and  nausea  and  vomiting  inci-
ence.
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Regarding  fetal  prognosis,  although  the  chosen  vasopres-
sor doses  were  suitable  for  maternal  hypotension  control  in
the three  groups,  the  newborns  of  mothers  who  received
ephedrine showed  pH  values  and  base  excess  lower  than  the
other groups.
Fetal acidosis,  assessed  through  umbilical  cord  blood
pH and  base  excess,  is  considered  a  marker  of  neona-
tal prognosis.  Although  some  studies  report  that  only
severely acidotic  fetuses  (pH  <  7),  after  an  acute  intra-
partum event,  have  a  higher  risk  of  mortality  and  morbidity
(hypoxic-ischemic encephalopathy,  intraventricular  hem-
orrhage, cerebral  palsy),  a  recent  meta-analysis  showed
that when  acidosis  was  deﬁned  as  pH  <  7.20,  a  four-  and
two-fold increase  occurred  in  mortality  and  morbidity,
respectively.34
According  to  Magalhães  et  al.18 who  used  the  value
of 7.20  to  characterize  fetal  acidosis  in  elective  cesarean
sections, in  which  patients  received  ephedrine  or  phenyle-
phrine, there  were  no  cases  of  fetal  acidosis.  In  this  work,
fetal acidosis  was  observed  in  only  three  newborns  of  Group
E; however,  p-value  was  not  signiﬁcant.  Despite  the  occur-
rence of  fetal  acidosis  in  the  three  cases  mentioned  above,
there were  no  clinical  consequences  in  any  of  them,  as  all
newborn had  Apgar  scores  >8  at  the  5th  minute  and  did  not
require resuscitation  maneuvers  or  transfer  to  the  intensive
care unit.
Base excess  comparison  showed  no  differences  between
the M  and  P  groups  compared  to  Group  E.  The  values  were
lower in  the  latter.  However,  despite  the  differences,  these
values are  within  normal  limits.35
From  fetal  standpoint,  no  doubt  that  phenylephrine
and metaraminol  are  associated  with  higher  values  of  pH
and base  excess  in  umbilical  cord  blood  that  were  higher
than those  of  ephedrine,2,15,36 which  were  conﬁrmed  in  the
present study,  reason  for  which  the  use  of  ephedrine  for
hypotension management  in  obstetric  anesthesia  is  being
questioned as  a  ﬁrst-choice  vasopressor.  Thus,  one  can  pre-
dict that  the  administration  of  high  doses  of  ephedrine,
especially in  situations  of  fetal  compromise,  should  be
avoided.15,37
Fetal  changes  caused  by  ephedrine  are  related  to  the  fact
that it  rapidly  crosses  the  uteroplacental  barrier,  stimulates
fetal -adrenergic  receptors,  and  increases  fetal  metabolic
demand. This  can  be  seen  by  the  increase  in  lactate,  glu-
cose, and  catecholamines  in  umbilical  cord  blood.  In  the
present study,  when  the  mother  received  phenylephrine,  the
lactate values  in  umbilical  cord  blood  were  higher  than  when
the mother  received  ephedrine  and  metaraminol.  However,
regarding glycemia,  there  were  no  differences  between  the
three groups,  in  contrast  to  the  results  of  Ngan  Kee  et  al.38
Fetal  metabolic  response  to  vasopressor  administered
in the  mother  may  depend  on  the  fetal  2-adrenoceptor
genotype and  further  complicate  the  understanding  of
the relationship  between  ephedrine  administration  and
lower pH  values.  Fetal  homozygosity  for  the  ADRB2  gene
p.Arg16 seems  to  be  more  resistant  to  ephedrine-induced
acidemia.39
On  the  other  hand,  a  recent  study  by  Bhardwaj  et  al.21showed  no  differences  between  the  M,  E,  and  P  groups
regarding pH  of  umbilical  cord  blood  and  base  excess  val-
ues. This  difference  probably  occurred  due  to  the  use  of
smaller doses  of  ephedrine.305
None  of  the  infants  in  this  study  had  low  Apgar  score
less than  7)  at  the  5th  minute.  It  is  known  that  episodes
f hypotension  during  elective  cesarean  sections  are  not  a
ause of  clinically  signiﬁcant  fetal  changes  when  treated
romptly. In  a  systematic  review  by  Veeser  et  al.19,  which
ncluded 20  studies  with  a  total  of  1069  newborns,  it  was
emonstrated that  only  one  newborn  had  Apgar  score  less
han 7  in  the  5th  minute.
In order  to  minimize  the  occurrence  of  fetal  acidosis,
n addition  to  the  approaches  already  described  here,  it  is
nown that  the  time  elapsed  between  the  skin  incision  and
irth, and  between  uterine  incision  and  birth,  is  directly
elated to  fetal  acidosis.  This  has  encouraged  surgeons  to
educe the  duration  of  surgeries.40
In  this  study,  the  duration  of  surgery  in  all  study  groups
as lower  than  that  reported  in  the  literature,  which  may
e a  reasonable  explanation  for  the  favorable  outcome  of
ewborns, even  in  cases  where  fetal  acidosis  occurred.  A
tudy by  Maayan-Metzger  et  al.  showed  that  infants  born
o women  who  had  an  interval  of  more  than  two  minutes
etween uterotomia  and  birth  had  a  higher  incidence  of
eeding problems  and  prolonged  hospitalization.41
Currently,  vasopressors  with  predominantly  alpha-agonist
ffects are  considered  drugs  of  choice  for  preventing
aternal hypotension,  nausea  and  vomiting  during  spinal
nesthesia for  elective  cesarean  sections.  Although  its  use
s  associated  with  reduced  heart  rate  and  cardiac  output,  it
s clinically  insigniﬁcant  in  low-risk  pregnancies  and  elective
esarean sections.
Our  results  show  that  in  elective  cesarean  sections  under
pinal anesthesia  hypotension  can  be  controlled  with  any
f the  vasopressors  studied,  as  there  were  no  clinically  sig-
iﬁcant maternal  or  fetal  changes,  which  shows  that  strict
ontrol of  blood  pressure  is  an  important  condition  for
aternal and  fetal  well-being.  However,  metaraminol  and
henylephrine had  advantages  over  ephedrine,  especially  in
he incidence  of  nausea  and  vomiting.  Repercussions  of  vaso-
ressor therapy  in  emergency  cesarean  sections  and  high  risk
regnancies are  still  a  matter  of  much  discussion.
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